561TiP A phase I dose-escalation study of ZN-d5, an BCL-2 inhibitor with improved selectivity, in patients with advanced non-Hodgkin lymphoma (NHL) or acute myeloid leukemia (AML)
| Autor: | Zaucha, J.M., Fiorino, T., Kalro, A., Shin, H-J., Viiala, N., Torres, L., Gordon, G., Kirshoff, R., Lopez, S., Makris, L., Miller, C., Park, S., Voliotis, D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S617-S617 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|